This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

In his response to this story mentioned above, Richards doesn't answer any of the stock ownership questions raised about his fund, Williams and Wurlitzer.

Efforts to reach Williams and Wurlitzer weren't successful. Wurlitzer has been published in two medical journals, according to a search of the PubMed database. The first, in 2003, was a comment on an article about physician-detectives in 20th century literature. The second Wurlitzer piece, from 2010, commented on an article describing burnout among U.S. surgeons.

Last fall, Richards wrote several
Seeking Alpha articles claiming
Roche(RHHBY) was in talks to buy Aeterna for "over $4.70 per share." No such deal has been announced.

In Tuesday trading, Keryx shares were dwon 16% to $4.13 while Aeterna shares were down 15% to $1.83.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;
click here to send him an email.